Washington Crossing, Pennsylvania
United States
85
2026-01-08
The entities that hold a legal rights for patent applications filed by inventor Macor John E.:
John E. Macor from Washington Crossing, US has applied for patents for these inventions. The list has both pending applications and granted patents:
MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
#2 | 2026-01-08MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
#3 | 2025-10-23COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
#4 | 2025-08-07MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
#5 | 2025-06-19MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
#6 | 2025-06-19MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
#7 | 2025-05-29ADENOSINE LIGANDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#8 | 2025-03-06AMINOTRIAZOLOPYRIDINES AS KINASE INHIBITORS
#9 | 2024-10-31BIARYL KINASE INHIBITORS
#10 | 2023-08-17[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS
#11 | 2023-06-22INDOLE CARBOXAMIDE COMPOUNDS
#12 | 2023-03-30Substituted indole compounds
#13 | 2022-12-011H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RIPK1)
#14 | 2022-10-06Aminotriazolopyridines as kinase inhibitors
#15 | 2021-10-07Indazole carboxamides as kinase inhibitors
#16 | 2021-09-23Dimethoxyphenyl substituted indole compounds as TLR7, TLR8 or TLR9 inhibitors
#17 | 2021-09-09Biaryl kinase inhibitors
#18 | 2021-08-19SUBSTITUTED INDOLE COMPOUNDS
#19 | 2021-04-29SELECTIVE NR2B ANTAGONISTS
#20 | 2021-04-15Indole carboxamide compounds
#21 | 2021-03-25[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
#22 | 2020-11-05Aminopyrrolotriazines as kinase inhibitors
#23 | 2020-10-08Biaryl kinase inhibitors
#24 | 2020-09-24(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZYL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
#25 | 2020-09-03Aminoimidazopyridazines as kinase inhibitors
#26 | 2020-08-13Carbazole derivatives
#27 | 2020-06-11Pyrimidine carboxamides as GSK-3 inhibitors
#28 | 2020-05-28INDOLE CARBOXAMIDE COMPOUNDS
#29 | 2020-05-28SELECTIVE NR2B ANTAGONISTS
#30 | 2020-04-16Selective NR2B antagonists
#31 | 2020-03-05Selective NR2B antagonists
#32 | 2020-02-06[1,2,4]triazolo[1,5-A]pyridinyl substituted indole compounds
#33 | 2019-12-26Aminotriazolopyridines as kinase inhibitors
#34 | 2019-12-05Biaryl kinase inhibitors
#35 | 2019-10-17GSK-3 inhibitors
#36 | 2019-10-17(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZYL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
#37 | 2019-10-17SELECTIVE NR2B ANTAGONISTS
#38 | 2019-09-26Heteroaryl substituted aminopyridine compounds
#39 | 2019-09-12GSK-3 inhibitors
#40 | 2019-08-29Pyridyl substituted indole compounds
#41 | 2019-08-15Indole carboxamide compounds
#42 | 2019-07-25Carbazole derivatives
#43 | 2019-05-02(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZYL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
#44 | 2019-04-25Indole carboxamide compounds
#45 | 2019-04-25SELECTIVE NR2B ANTAGONISTS
#46 | 2019-02-07Biaryl kinase inhibitors
#47 | 2018-12-06Biaryl kinase inhibitors
#48 | 2018-11-01Selective NR2B antagonists
#49 | 2018-11-01Selective NR2B antagonists
#50 | 2018-09-06(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZYL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
#51 | 2018-09-06SELECTIVE NR2B ANTAGONISTS
#52 | 2018-06-28Heteroaryl substituted aminopyridine compounds
#53 | 2018-05-24Fused pyridines as kinase inhibitors
#54 | 2018-05-17Biaryl kinase inhibitors
#55 | 2018-04-26SELECTIVE NR2B ANTAGONISTS
#56 | 2018-04-19(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZYL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
#57 | 2018-01-04SELECTIVE NR2B ANTAGONISTS
#58 | 2018-01-04[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
#59 | 2017-11-30(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZYL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
#60 | 2017-09-14Indole carboxamide compounds
#61 | 2017-09-14Heterocyclic kinase inhibitors
#62 | 2017-09-14Selective NR2B Antagonists
#63 | 2017-08-24QUINAZOLINE-BASED KINASE INHIBITORS
#64 | 2017-08-03(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZYL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
#65 | 2017-06-29Biaryl kinase inhibitors
#66 | 2017-03-09(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZYL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
#67 | 2016-11-17ARYL LACTA KINASE INHIBITORS
#68 | 2016-11-17Quinoline-based kinase inhibitors
#69 | 2016-10-06Substituted pyridine derivatives useful as GSK-3 inhibitors
#70 | 2016-09-22GSK-3 inhibitors
#71 | 2016-08-25Pyrrolotriazine kinase inhibitors
#72 | 2016-08-18Triazolopyridine ether derivatives and their use in neurological and pyschiatric disorders
#73 | 2016-08-18Oxazolidinones as modulators of mGluR5
#74 | 2016-08-04ARYL ETHER-BASE KINASE INHIBITORS
#75 | 2016-07-14IMIDAZOPYRIDAZINE KINASE INHIBITORS USEFUL TO TREATING A DISEASE OR DISORDER MEDIATED BY AAK1, SUCH AS ALZHEIMER'S DISEASE, BIPOLAR DISORDER, PAIN, SCHIZOPHRENIA
#76 | 2016-06-02Aryl lactam kinase inhibitors
#77 | 2016-04-28Indole carboxamide compounds
#78 | 2016-04-14QUINUCLIDINE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
#79 | 2016-03-24Selective NR2B Antagonists
#80 | 2016-02-04(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZYL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
#81 | 2016-01-21Aryl amide-based kinase inhibitors
#82 | 2015-12-03QUINUCLIDINE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
#83 | 2015-11-26COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION
#84 | 2015-07-09()-3-((3,4)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one and its prodrugs for the treatment of psychiatric disorders
#85 | 2015-06-04COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION
1180472 ⎘